Navigation Links
RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs

as a drug target, Li et al (6) used siRNAs to reduce cyclin E expression in hepatocellular carcinoma (HCC) cells. As expected, the cyclin E siRNA promoted apoptosis of HCC cells and blocked cell proliferation. In addition, the cyclin E siRNA inhibited HCC tumor growth in nude mice demonstrating the potential for creating drugs targeting cyclin E.


Pathway Analysis
Another key application for siRNAs is pathway analysis. Reducing the expression of a single gene has implications on the expression and activities of genes that are in the same pathway(s). For instance, reducing the levels of a transcription factor such as p53 will reduce the expression of any gene that relies on the p53 transcription factor for activity. Furthermore, the expression of genes that are regulated by gene products that are controlled by p53 should likewise be impacted. Treating cells with an siRNA targeting a given gene and then monitoring the expression of other genes using a microarray will make it possible to identify genes that are associated with the target gene. Furthermore, a specific pathway can be dissected by treating cells sequentially with siRNAs targeting the various genes in the pathway and assaying which genes are affected. This will make it possible to assign a position in the pathway for each gene.

* Ramos-Nino et al (7) exposed RPM cells to crocidolite asbestos and monitored gene expression using arrays. Genes were ca
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. An Epitope Tagging Vector for Gene Expression in Mammalian Cells
4. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
5. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
6. A New Lambda Vector for Mammalian Expression
7. Mammalian and Bacterial Expression in One Vector
8. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
9. Mammalian Expression Vectors with Interchangeable Selectable Markers
10. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
11. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: RNAi Tool for Mammalian Gene Analysis Applications siRNAs

(Date:11/6/2009)...- Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) (...ated results from a Phase II study of intravenous ...o the lung in a poster presentation at the 15th An...ld in Miami Beach, Florida, from November 5th to 7...Study of Intravenous REOLYSIN (Wild-type Reovirus)...
(Date:11/5/2009)...irstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today a...er ended September 30, 2009. GenVec reported a net...ree months ended September 30, 2009 compared to a ...comparable quarter of 2008. For the nine months en...1 million ($0.15 per share), compared to a net los...
(Date:11/5/2009)...ire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KO...r processing and storing adult stem cells, today r...10. ,, For the quarter ended September 30, 2009... 15 percent increase over revenues of $4.5 million... the key contributors to the growth in revenues in...
(Date:11/5/2009)...irstCall/ -- Cepheid (Nasdaq: CPHD ) today announ...llowing investor conferences, and invited investor...Credit Suisse Healthcare Conference, Phoenix, AZ, ...a.m. Mountain Time, NASDAQ OMX 23... Tuesday, 1 December, 2009 at 10.45 a.m. Greenw...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...b. 26 Ardea Biosciences,Inc. (Nasdaq: RDEA ) tod...ase Scientific Advisory Board (SAB). The SAB will ...to the Company regarding key decisions,relating to...ronic,inflammatory diseases, such as gout and rheu...oup of international authorities in gout,and arthr...
... join the Company, NATICK, Mass., Feb. 26 Boston...ced that Jay J. Schnitzer, M.D., Ph.D.,will be joi...effective,March 24., Dr. Schnitzer will serve as ..., sitting on the Clinical Leadership team and repo... Dr. Donald S. Baim, M.D. In his new role,Dr. Schn...
... Expert Opinion provides systematic,and authoritat... to access,and track key developments that lead to...macotherapy, Expert Opinion on Biological Therapy ...accepting original research., Why publish with Ex...lish independent and authoritative,peer-reviewed a...
Other Biology Technology:Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3Boston Scientific Announces Addition to Clinical Sciences Organization 2Boston Scientific Announces Addition to Clinical Sciences Organization 3Boston Scientific Announces Addition to Clinical Sciences Organization 4Three Expert Opinion Journals now Publishing Original Research 2
(Date:11/4/2009)...s, MO, November 4, 2009 Childhood obesity in the ...th more than one fourth of advertising on daytime ...erages and continuing questions about the role tel...December issue of the Journal of Nutrition Educat...med at children might be a large contributor to th...
(Date:11/4/2009)...apore laboratory that deciphered the DNA codes, or...ephant shark, has joined The Genome 10K Project, a...sitory of DNA sequences on 10,000 species of anima...hat currently can not be achieved. , Participati... published in the Nov. 5, 2009 issue of the Journ...
(Date:11/4/2009)...OLA VALLEY, Calif., Oct. 19 Spectr...ar sensing and imaging devices which shed light on...t has signed exclusive distribution deals for both... The markets covered include Australia, New Zeala...), Suriname, Italy, France, Spain, Portugal, Polan...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2Spectros Signs New International Distribution Deals 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3Healthy Gums and a Healthy Heart 3A The Perio Cardio Connection 47426 1Healthy Gums and a Healthy Heart 3A The Perio Cardio Connection 47426 2Healthy Gums and a Healthy Heart 3A The Perio Cardio Connection 47426 3Healthy Gums and a Healthy Heart 3A The Perio Cardio Connection 47426 4Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 1Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 2Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 3Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 4Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 5
...f. As Aesop said, appearances are deceivingeven in... the 1880s, clinging to the sides of an aquarium, ...ent of Energy Joint Genome Institute (DOE JGI), a ... appears to harbor a far more complex suite of cap...ed in the August 21 online edition of the journal ...
... GEOLOGY topics reach deep into Earth and far into...t and asteroidsand touch on the intricate details ...als and coral reef health and the wealth of climat...hinese loess. The GSA TODAY article studies the en...mining long-term environmental stress and recovery...
..., 2008 Noise can be irritating and possibly harm...even 60-foot whales in the Gulf of Mexico. , In...e noise may be a cause of stress for dolphins, wha... five-year study show that noise pollution especi...physical exploration for oil and gas seems to hav...
Other Biology News:Genome of simplest animal reveals ancient lineage, confounding array of complex capabilities 2Genome of simplest animal reveals ancient lineage, confounding array of complex capabilities 3September Geology and GSA Today media highlights 2September Geology and GSA Today media highlights 3September Geology and GSA Today media highlights 4September Geology and GSA Today media highlights 5September Geology and GSA Today media highlights 6September Geology and GSA Today media highlights 7September Geology and GSA Today media highlights 8September Geology and GSA Today media highlights 9September Geology and GSA Today media highlights 10September Geology and GSA Today media highlights 11September Geology and GSA Today media highlights 12Unique study shows oil, gas seismic work not affecting Gulf sperm whales 2Unique study shows oil, gas seismic work not affecting Gulf sperm whales 3
COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Growth Hormone from Cell Sciences
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: